相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration
Virpi Talman et al.
CELL AND TISSUE RESEARCH (2016)
Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation
Neha Rani et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling
Merry L. Lindsey et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Chrysin attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway
Cornel Balta et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2015)
Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis
Johan M. Lorenzen et al.
EUROPEAN HEART JOURNAL (2015)
Building a better infarct: Modulation of collagen cross-linking to increase infarct stiffness and reduce left ventricular dilation post-myocardial infarction
Andrew P. Voorhees et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition
Min-Kyung Kang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
Inhibition of TGF-beta by a novel PPAR-gamma agonist, chrysin, salvages beta-receptor stimulated myocardial injury in rats through MAPKs-dependent mechanism
Neha Rani et al.
NUTRITION & METABOLISM (2015)
Chrysin alleviates isoproterenol-induced myocardial infarction in diabetic rats through modulation of PPAR-gamma
N. Rani et al.
CARDIOVASCULAR RESEARCH (2014)
Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis
Eman M. Mantawy et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2014)
Fibroblasts in myocardial infarction: A role in inflammation and repair
Arti V. Shinde et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Beneficial effects of Chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis
Nemat Ali et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2014)
PPAR-γ activation by rosiglitazone suppresses angiotensin II-mediated proliferation and phenotypictransition in cardiac fibroblasts via inhibition of activation of activator protein 1
Xiaoyang Hou et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Telmisartan, a unique ARB, improves left ventricular remodeling of infarcted heart by activating PPAR gamma
Yasuhiro Maejima et al.
LABORATORY INVESTIGATION (2011)
Extracellular matrix fibrotic markers in heart failure
Faiez Zannad et al.
HEART FAILURE REVIEWS (2010)
Proteomic analysis identifies in vivo candidate matrix metalloproteinase-9 substrates in the left ventricle post-myocardial infarction
Rogelio Zamilpa et al.
PROTEOMICS (2010)
Pioglitazone Improves Cardiac Function and Alters Myocardial Substrate Metabolism Without Affecting Cardiac Triglyceride Accumulation and High-Energy Phosphate Metabolism in Patients With Well-Controlled Type 2 Diabetes Mellitus
Rutger W. van der Meer et al.
CIRCULATION (2009)
Inhibition of NF-kappa B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction
Yasuyuki Onai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
An overview on biological mechanisms of PPARs
BP Kota et al.
PHARMACOLOGICAL RESEARCH (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart
K Trescher et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2004)
Angiotensin II regulation of collagen type I expression in cardiac fibroblasts -: Modulation by PPAR-γ ligand pioglitazone
K Chen et al.
HYPERTENSION (2004)
Peroxisome proliferator-activated receptor-α and receptor-γ activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension
M Iglarz et al.
HYPERTENSION (2003)
Peroxisome proliferator-activated receptor-alpha and receptor-gamma activators prevent cardiac fibrosis in mineralocorticoid-dependent hypertension
M Iglarz et al.
HYPERTENSION (2003)
A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers
MR Bergman et al.
BIOCHEMICAL JOURNAL (2003)
Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction
T Shiomi et al.
CIRCULATION (2002)
Effects of chronic chrysin treatment in spontaneously hypertensive rats
IC Villar et al.
PLANTA MEDICA (2002)
Rosiglitazone, a peroxisome proliferator-activated receptor-γ, inhibits the Jun NH2-terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injury
N Khandoudi et al.
DIABETES (2002)
Suppression of inducible cyclooxygenase and nitric oxide synthase through activation of peroxisome proliferator-activated receptor-γ by flavonoids in mouse macrophages
YC Liang et al.
FEBS LETTERS (2001)
Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-γ and nuclear factor-κB
SW Chung et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Peroxisome proliferator-activated receptor activators inhibit lipopolysaccharide-induced turner necrosis factor-α expression in neonatal rat cardiac myocytes
H Takano et al.
CIRCULATION RESEARCH (2000)
Peroxisome proliferator-activated receptor γ-dependent repression of the inducible nitric oxide synthase gene
M Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
A Ducharme et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
